Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Phospho-PAK4/5/6 (Ser474/Ser602/Ser560) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-Paxillin (Y118) Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details

Phospho-PBK (Thr9) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-PBK/TOPK (Thr9) Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details

Phospho-PDGF Receptor beta (Tyr1021) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-PKA C alpha/beta/gamma (T197) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-PKC delta (Thr507) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-PKC epsilon (Ser729) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-PKD2 (Ser876) Recombinant Antibody


Bioss logo
View Antibody details

Phospho-PKR (T451) Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details